Cargando…
COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
The interplay between the virus, infected cells and immune responses to SARS-CoV-2 is still under debate. By extending the basic model of viral dynamics, we propose here a formal approach to describe neutralisation versus weak (or non-)neutralisation scenarios and compare them with the possible effe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375081/ https://www.ncbi.nlm.nih.gov/pubmed/35962852 http://dx.doi.org/10.1007/s10441-022-09447-1 |
_version_ | 1784767883735203840 |
---|---|
author | Danchin, Antoine Pagani-Azizi, Oriane Turinici, Gabriel Yahiaoui, Ghozlane |
author_facet | Danchin, Antoine Pagani-Azizi, Oriane Turinici, Gabriel Yahiaoui, Ghozlane |
author_sort | Danchin, Antoine |
collection | PubMed |
description | The interplay between the virus, infected cells and immune responses to SARS-CoV-2 is still under debate. By extending the basic model of viral dynamics, we propose here a formal approach to describe neutralisation versus weak (or non-)neutralisation scenarios and compare them with the possible effects of antibody-dependent enhancement (ADE). The theoretical model is consistent with the data available in the literature; we show that both weakly neutralising antibodies and ADE can result in final viral clearance or disease progression, but that the immunodynamics are different in each case. As a significant proportion of the world’s population is already naturally immune or vaccinated, we also discuss the implications for secondary infections after vaccination or in the presence of immune system dysfunctions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10441-022-09447-1. |
format | Online Article Text |
id | pubmed-9375081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-93750812022-08-15 COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios Danchin, Antoine Pagani-Azizi, Oriane Turinici, Gabriel Yahiaoui, Ghozlane Acta Biotheor Regular Article The interplay between the virus, infected cells and immune responses to SARS-CoV-2 is still under debate. By extending the basic model of viral dynamics, we propose here a formal approach to describe neutralisation versus weak (or non-)neutralisation scenarios and compare them with the possible effects of antibody-dependent enhancement (ADE). The theoretical model is consistent with the data available in the literature; we show that both weakly neutralising antibodies and ADE can result in final viral clearance or disease progression, but that the immunodynamics are different in each case. As a significant proportion of the world’s population is already naturally immune or vaccinated, we also discuss the implications for secondary infections after vaccination or in the presence of immune system dysfunctions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10441-022-09447-1. Springer Netherlands 2022-08-13 2022 /pmc/articles/PMC9375081/ /pubmed/35962852 http://dx.doi.org/10.1007/s10441-022-09447-1 Text en © Prof. Dr. Jan van der Hoeven stichting voor theoretische biologie 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Regular Article Danchin, Antoine Pagani-Azizi, Oriane Turinici, Gabriel Yahiaoui, Ghozlane COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios |
title | COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios |
title_full | COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios |
title_fullStr | COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios |
title_full_unstemmed | COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios |
title_short | COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios |
title_sort | covid-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375081/ https://www.ncbi.nlm.nih.gov/pubmed/35962852 http://dx.doi.org/10.1007/s10441-022-09447-1 |
work_keys_str_mv | AT danchinantoine covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios AT paganiazizioriane covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios AT turinicigabriel covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios AT yahiaouighozlane covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios |